Placebo controlled, double blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors (PROMID): Results on long-term survival - Arnold, R; Wittenberg, M; Rinke, A (2013)
(suppl; abstr 4030)